Medicare and Medicaid would test lower prices for many drugs by comparing them with prices in other wealthy countries. The test would run for 5 years starting in 2029. Drug makers would face new price reporting rules and could sign special agreements tied to more U.S. manufacturing.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Most Favored Patient Act of 2026 is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Latest action on H.R. 7837: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who this affects: This bill mainly affects people who get covered drugs through Medicaid, Medicare Part D drug plans, or Medicare Part B. It could change what those programs pay and what some patients pay out of pocket. It also affects drug makers that sell covered drugs, because they would face new price reporting rules and pressure to offer lower prices. Federal health officials would have to run the 5-year test, calculate prices, review agreements, and report to Congress.
Why this matters: This bill matters because it could lower what Medicare and Medicaid pay for some costly drugs, which could also lower some patients’ out-of-pocket costs. The exact savings are not clear from the bill. The plan could also change how drug makers set prices, share data, and decide where to make drugs. Because this is a 5-year test, its results could shape future drug pricing policy.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
